{"id":1826,"date":"2023-11-14T11:42:26","date_gmt":"2023-11-14T10:42:26","guid":{"rendered":"https:\/\/galpharma.tn\/?post_type=medicament&#038;p=1826"},"modified":"2023-11-18T09:25:20","modified_gmt":"2023-11-18T08:25:20","slug":"copred-odt","status":"publish","type":"medicament","link":"https:\/\/galpharma.tn\/en\/medicaments\/copred-odt\/","title":{"rendered":"COPRED ODT"},"content":{"rendered":"<p>1) Collagenosis, connective tissue disease: &#8211; Progressive outbreaks of systemic diseases, in particular: systemic lupus erythematosus, vasculitis, polymyositis, visceral sarcoidosis. 2) Dermatological: &#8211; Severe autoimmune bullous dermatoses, in particular pemphigus and bullous pemphigoid. &#8211; Serious forms of angiomas in infants. &#8211; Certain forms of lichen planus. &#8211; Certain acute urticaria. &#8211; Serious forms of neutrophilic dermatoses. 3) Digestive: &#8211; Progressive outbreaks of ulcerative colitis and Crohn&#8217;s disease. &#8211; Chronic active autoimmune hepatitis (with or without cirrhosis). &#8211; Severe acute alcoholic hepatitis, histologically proven. 4) Endocrine: &#8211; Severe subacute de Quervain thyroiditis. &#8211; Certain hypercalcemia. 5) Hematological: &#8211; Severe immunological thrombocytopenic purpuras. &#8211; Autoimmune hemolytic anemia. &#8211; In combination with various chemotherapies in the treatment of lymphoid malignancies. &#8211; Chronic, acquired or congenital erythroblastopenia. 6) Infectious: &#8211; Tuberculous pericarditis and serious forms of life-threatening tuberculosis. &#8211; Pneumocystis carinii pneumonia with severe hypoxia. 7) Neoplastics: &#8211; Antiemetic treatment during antineoplastic chemotherapy. &#8211; Edematous and inflammatory flare-up associated with antineoplastic treatments (radio and chemotherapy). 8) Nephrological: &#8211; Nephrotic syndrome with minimal glomerular lesions. &#8211; Nephrotic syndrome of primary segmental and focal hyalinoses. &#8211; Stages III and IV of lupus nephropathy. &#8211; Intrarenal granulomatous sarcoidosis. &#8211; Vasculitis with renal damage. &#8211; Primary extracapillary glomerulonephritis. 9) Neurological: &#8211; Myasthenia. &#8211; Cerebral edema of tumor cause.<\/p>\n<p>&#8211; Chronic, idiopathic, inflammatory polyradiculoneuropathy. &#8211; Infantile spasm (West syndrome), Lennox-Gastaut syndrome. &#8211; Multiple sclerosis in flare-up, following intravenous corticosteroid therapy. 10) Ophthalmological: &#8211; Severe anterior and posterior uveitis. &#8211; Edematous exophthalmos. &#8211; Certain optic neuropathies, following intravenous corticosteroid therapy (in this indication, the oral route as first intention is not recommended). 11)ENT: &#8211; Certain serous otitis. &#8211; Nasosinusal polyposis. &#8211; Certain acute or chronic sinusitis. &#8211; Seasonal allergic rhinitis in short course. &#8211; Acute stridular laryngitis (subglottic laryngitis) in children. 12) Respiratory: &#8211; Persistent asthma preferably in a short course in the event of failure of high-dose inhalation treatment. &#8211; Exacerbations of asthma, particularly severe acute asthma. &#8211; Chronic obstructive pulmonary disease in evaluation of the reversibility of the obstructive syndrome. &#8211; Progressive sarcoidosis. &#8211; Diffuse interstitial pulmonary fibrosis. 13) Rheumatological: &#8211; Rheumatoid arthritis and certain polyarthritis. &#8211; Rhizomelic pseudopolyarthritis and Horton&#8217;s disease. &#8211; Acute articular rhumatism. &#8211; Severe and intractable cervicobrachial neuralgia. 14) Allogeneic organ and hematopoietic stem cell transplantation: &#8211; Prophylaxis or treatment of graft rejection. &#8211; Prophylaxis or treatment of graft-versus-host disease.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1) Collagenosis, connective tissue disease: &#8211; Progressive outbreaks of systemic diseases, in particular: systemic lupus erythematosus, vasculitis, polymyositis, visceral sarcoidosis. 2) Dermatological: &#8211; Severe autoimmune bullous dermatoses, in particular pemphigus and bullous pemphigoid. &#8211; Serious forms of angiomas in infants. &#8211; Certain forms of lichen planus. &#8211; Certain acute urticaria. &#8211; Serious forms of neutrophilic [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","class_list":["post-1826","medicament","type-medicament","status-publish","hentry","dci-prednisolone-2","class_therapeutique-anti-inflamatories","galenique-orodispersible-tablet"],"_links":{"self":[{"href":"https:\/\/galpharma.tn\/en\/wp-json\/wp\/v2\/medicament\/1826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/galpharma.tn\/en\/wp-json\/wp\/v2\/medicament"}],"about":[{"href":"https:\/\/galpharma.tn\/en\/wp-json\/wp\/v2\/types\/medicament"}],"wp:attachment":[{"href":"https:\/\/galpharma.tn\/en\/wp-json\/wp\/v2\/media?parent=1826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}